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Letter to the EditorEpidermal equivalents of filaggrin
null keratinocytes do not show
impaired skin barrier functionTo the Editor:
The discovery that null alleles of the filaggrin (FLG) gene are a
strong genetic risk factor for atopic dermatitis (AD) has caused a
paradigm shift in understanding the etiology of this disease.1
FLG-deficient mouse models showed barrier impairment and
enhanced percutaneous allergen sensitization, exemplifying the
potential functional consequences of insufficient FLG expres-
sion.2 Both in patients with AD carrying FLG mutations and in
FLG-proficient patients, increased transepidermal water loss
(TEWL) and skin permeability were noted in nonlesional skin,
suggesting that skin barrier abnormalities are a general phenom-
enon in AD, not necessarily restricted to FLGmutations.3 Others
reported a mild increase in TEWL in patients with ichthyosis vul-
garis (IV) carrying 2 FLG null alleles, but failed to demonstrate
increased TEWL in heterozygous carriers of an FLG null allele.4
It could be argued that in vivo there may be confounding factors
such as concomitant subclinical inflammation of the apparently
normal skin that would obscure the effect of FLG deficiency on
barrier function per se. For this reason, 3-dimensional (3D) skin
models represent excellent models to investigate skin barrier
function in a well-controlled setting. In vitro studies using
various keratinocyte sources, 3D models, FLG gene knockdown
approaches, and barrier assays have been published (summarized
in Table E1 in this article’s Online Repository at www.jacionline.
org). Because of different experimental procedures, these studies
appear contradictory and are difficult to interpret. None of them
used genetically definedFLG null (FLG2/2) orFLG1/2 keratino-
cytes, but all relied on gene knockdown approaches to lower FLG
expression levels. In this study, we have used human epidermal
equivalents (HEEs) generated from FLG null keratinocytes
derived from patients with IV to study the effect on epidermal
differentiation and barrier function, without confounding factors.
We analyzed the outside-in and inside-out barrier of these
equivalents using low molecular weight tracers as previously
used in other studies. Remarkably, we did not observe altered
skin barrier function in HEEs of completely FLG-deficient
keratinocytes.
All procedures for cell culture, cytokine stimulation, analysis
of gene and protein expression, and epidermal barrier function
were performed as described in this article’s Methods section in
the Online Repository at www.jacionline.org. Experiments were
performed on fully differentiated HEEs expressing all markers
of normal skin (see Fig E1 in this article’s Online Repository at
www.jacionline.org). For the FLG2/2 HEEs, we used
keratinocytes isolated from patients with IV (N5 5) which carry
the 2 most frequent mutations of the FLG gene, leading to
complete absence of FLG protein as verified by immunohisto-
chemistry (see Fig E2 in this article’s Online Repository at
www.jacionline.org). Healthy volunteer keratinocytes (N 5 6)
were used as control (FLG1/1). We also considered the 2016 The Authors. Published by Elsevier Inc. on behalf of the American Academy of
Allergy, Asthma & Immunology. This is an open access article under the CC BY-NC-
ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).possibility that the FLG genotype may drive skin barrier
impairment depending on a concomitant TH2-cytokine milieu.
We therefore compared FLG2/2 and FLG1/1 HEEs with and
without stimulation by TH2 cytokines IL-4 and IL-13 during the
entire air-liquid interface culture (Fig 1). Overall, despite the
absence of keratohyalin granules and FLG protein in FLG2/2
HEEs, we found no major differences between FLG2/2 and
FLG1/1 HEEs concerning general epidermal development, strat-
ification, and morphology. The stratum corneum (SC) of FLG2/2
HEEs was found to be marginally thinner but this was not signif-
icant (Fig 1; see Fig E3 in this article’s Online Repository at www.
jacionline.org). TH2 cytokines induced thickening of the viable
epidermis (Fig E3), spongiosis, and apoptosis, as we have
described previously.5 Differentiation proteins were strongly
downregulated by TH2 cytokine treatment as reported before
6;
however, expression levels were equal for both FLG genotypes
(Fig 1, A). Quantitative PCR analysis revealed that TH2 cytokine
stimulation caused a significant decrease in the expression of
many genes that encode structural SC proteins (see Figs E4 and
E5 in this article’s Online Repository at www.jacionline.org).
However, these were, with the exception of loricrin and caspase
14, not significantly different between the 2 FLG genotypes.
Because tight junctions (TJs) are important in epidermal barrier
formation, we analyzed the expression of TJ proteins of our
HEEs. Occasionally, we observed a patchy expression of
claudin-4 (Cldn-4) and occludin (Ocln) in FLG2/2 HEEs
compared with the continuous expression in FLG1/1 HEEs
(Fig 1, B). A previous study in mice, however, reported that the
epidermal TJ barrier is not affected by the loss of filaggrin.7
In vitro epidermal barrier function of the HEEs described above
was assessed by outside-in and inside-out tracer penetration
assays (Lucifer Yellow [LY] and EZ-Link Sulfo-NHS-LC-LC-
Biotin). To validate the LY penetration assay for the detection
of SC defects in our system, we used the detergent SDS as a
positive control to compromise the HEE barrier capacity. We
found LY penetration through the SC reaching the keratinocytes
of the living epidermis following SDS treatment (see Fig E6 in
this article’s Online Repository at www.jacionline.org). Interest-
ingly, under normal conditions as well as in a TH2 cytokine
milieu, where expression of most structural proteins was strongly
diminished, both SC of FLG1/1 and FLG2/2 HEEs appeared
impermeable for LY (Fig 1, C) and EZ-Link Sulfo-NHS-LC-
LC-Biotin (see Fig E7 in this article’s Online Repository at
www.jacionline.org) when applied at the SC side of the HEE.
The inside-out barrier with respect to water evaporation across
the SC was measured by TEWL determination of FLG1/1 and
FLG2/2 HEEs. No differences were found between the groups
(Fig 1, D). In addition, we used EZ-Link Sulfo-NHS-LC-LC-
Biotin inside-out diffusion to investigate SC permeability in
HEEs of both genotypes (Fig 1, E). Again, no differences were
found.
As sensitization against environmental antigens is a hallmark
of AD, a leaky skin barrier has been postulated as the most
plausible mechanism linking genetic alterations to disease
phenotype. Conflicting outcomes of studies that have addressed
this question during the last years (Table E1) may be caused by
differences in experimental setup or the lack of proper controls.
Insufficient numbers of biological replicates, and off-target1
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have played a role. Most of these studies obtained a significant
reduction in FLG mRNA or protein expression (70% to 90%),
but none of them reached complete absence of expression. We
used genetically defined keratinocytes, completely deficient of
FLG protein, in a 3D epidermal equivalent model. This
provided a unique possibility to study the role of FLG in skin
barrier defects, reported for both IV and AD. Thereby,
knockdown-derived off-target effects were excluded, while
potential compensatory mechanisms by naturally occurring
FLG deficiency were taken into account.
In our study, barrier function was tested by the polar solutes LY
and biotin as these are commonly used in comparable studies.
Although alteration of the permeability for these low molecular
weight tracers was not observed, this does not completely rule out
alterations of FLG-deficient epidermis with respect to perme-
ability for environmental molecules with other biophysical
properties such as microbial or airborne antigens, or fragments
thereof. As microbiome alterations (eg, Staphylococcus aureus
colonization) may play a role in AD, the penetration of
environmental stimuli may be the result of an interaction between
microorganisms and genetic factors such as FLG mutations, as
suggested in a recent study.8 Clearly, this is an interesting area
for future research.
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METHODS
Primary keratinocyte isolation
Primary human keratinocytes were obtained from four 4-mm diameter
punch biopsies of genotyped healthy volunteers (FLG1/1) and patients with
IV (FLG2/2), which were taken at the upper buttock by a dermatologist.
All volunteers (aged between 25 and 65 years) signed informed consent for
this study. Keratincoytes were isolated and expanded according to the
Rheinwald-Green protocolE7 and stored in liquid nitrogen.
Filaggrin genotyping
FLG mutation analysis for the 2 most common mutations, R501X and
2282del4, was performed as described previously.E8
3D HEE development
For the generation of HEEs, 300,000 primary human keratinocytes were
seeded onto 0.4 mm pore size transwell filters (Thincerts, Greiner Bio-One
GmbH, Frickenhausen, Germany). Before seeding, these transwells were
incubated with 100 mg/mL rat-tail collagen (BD Biosciences, Breda, The
Netherlands) diluted in sterile cold PBS at 48C for 1 hour, or with 100 mg/mL
fibrinogen, 10% FCS (HyClone), or 100 mg/mL poly-D-lysine at room
temperature for 1 hour. Afterward, excessive coating solutions were carefully
aspirated and filters were washed once with cold, sterile PBS. First, the
primary keratinocytes were cultured in a submerged manner in proliferation
medium (CnT-prime, CELLnTEC) for 2 days to form a homogeneously
distributed monolayer. One day later, medium was changed to differentiation
medium (60% 3D barrier, CELLnTEC complemented with 40% Dulbecco
modified Eagle medium, Gibco, Life Technologies, Thermo Scientific,
Bleiswijk, The Netherlands). On the third day, the transwell inserts were lifted
to the air-liquid interface to induce differentiation and stratification of the
epidermis. From now on, cells were cultured in differentiation medium until
the end of the culture and they were refreshed with differentiation medium
every other day. This HEE culture schedule is depicted in Fig E1.
TH2 cytokine stimulation of HEEs
For TH2 cytokine stimulation, a mixture of 50 ng/mL IL-4 (Preprotech) and
50 ng/mL IL-13 (Preprotech, Rocky Hill, NJ) in HEE differentiation medium
containing 0.05% BSA (Sigma-Aldrich, Zwijndrecht, The Netherlands) was
added from day 1 of air-liquid interface culture until the end of the culture
of the HEEs.
In vitro outside-in epidermal permeability assay
LY (1 mM) (Sigma-Aldrich, Zwijndrecht, The Netherlands) or EZ-Link
Sulfo-NHS-LC-LC-Biotin (Life Technologies) was added epicutaneously
onto the HEE for 60 minutes, followed by formalin fixation and processing for
histology. Sections (6 mm) were counterstained with 49,6-diamidino-2-
phenylindole (Boehringer Mannheim, Mannheim, Germany) and assessed
with fluorescence microscopy for LY penetration or stained with an indirect
immunoperoxidase technique (Vectastain, Vector Laboratories, Burlingame,
Calif) for EZ-Link Sulfo-NHS-LC-LC-Biotin penetration.
To show LY penetration on impaired skin barrier function in vitro, HEEs
were topically treated with 0.5% SDS in PBS (Sigma-Aldrich) for 90 minutes
followed by a 60-minute incubation with 1 mM LY as described above.
In vitro inside-out epidermal permeability assay
Fully differentiated HEEs residing in the transwell were placed
upside-down. EZ-Link Sulfo-NHS-LC-LC-Biotin (Life Technologies,
Thermo Scientific, Bleiswijk, The Netherlands) in HEE differentiation
medium was applied to the basal layer side of the HEE for 60 minutes,
followed by formalin fixation and processing for histology. For visualization,
6-mm sections were stained with streptavidin Alexa Fluor 594 (Life
Technologies, Thermo Scientific) and counterstained with 49,6-diamidino-2-
phenylindole (Boehringer Mannheim) and assessed with fluorescence
microscopy dye penetration.
TEWL analysis
Permeability barrier function was evaluated by measurement of TEWL
with a condenser-chamber method (Aquaflux AF200, Biox Systems, London,
United Kingdom). The HEEs, maintained in tissue culture exerts along with
their medium, were first acclimatized to the ambient conditions of temperature
and humidity for at least 30 minutes. The measurement head of the instrument
was equipped with a stainless steel extension tube (5-mm bore diameter) to
reach down into the transwell inserts. A gentle and controlled contact pressure
of the tube onto the sample surface was achieved by mounting the
measurement head on a purpose-designed probe holder with precise control
of the vertical position of the probe. The same investigator performed all
TEWL measurements. For each HEE, TEWL measurements were performed
in triplicate and then averaged.
Immunohistochemistry
HEEs were fixed in formalin and processed for routine histology.
Paraffin sections (6 mm) were stained with antibodies using an indirect
immunoperoxidase technique (Vectastain, Vector Laboratories, Burlingame,
Calif) or immunofluorescence technique according to Gruber et al.E9 An
overview of all used antibodies is presented in Table E2.
Quantitative real-time PCR
RNA isolation, cDNA synthesis, and quantitative PCR analysis were
performed as described earlier.E10 All primers were designed and used as
described previously.E11 Target gene expression was normalized to the
expression of the house keeping gene human acidic ribosomal phosphoprotein
P0 (RPLP0). The DDCt method was used to calculate relative mRNA
expression levelsE12 (see Table E3 for primer sequences).
Quantitative PCR data were analyzed using 2-way ANOVA to test
the effect of both FLG genotype and TH2 cytokine stimulation on
mRNA expression. For this, we used the DCt values of n 5 11 HEEs (n 5 6
FLG1/1, n 5 5 FLG2/2).
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FIG E1. Development of the 3D human epidermal equivalent model. A, Keratinocytes are seeded into
proliferation medium (PM) and submerged in a transwell system to form a confluent monolayer. After
2 days, the medium is exchanged to differentiation medium (DM) and after 1 more day the inserts are lifted
to the air-liquid interface to grow for another 8 days in the DM. B, H&E staining of the keratinocyte
monolayer on the insert at day 0, comparing rat-tail collagen-coated transwells to uncoated ones
(left panel). The arrow indicates keratinocyte colonies, whereas the circle depicts empty filter spaces.
Corresponding H&E staining of the epidermal equivalents at the end of air-liquid interface culture (day 8,
right panel). C, H&E staining of epidermal equivalents cultured 6, 8, or 11 days at the air-liquid interface
shows that optimal stratification of an epidermis is reached after 8 days. D, Protein expression of
proliferation (Ki67) and differentiation (K10, IVL, FLG) markers show that these HEEs exhibit normal
protein expression comparable to human epidermis in vivo. FLG, Filaggrin; H&E, hematoxylin and eosin;
IVL, involucrin; K10, cytokeratin 10. Scale bar 5 100 mm.
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FIG E2. Filaggrin null-mutation. A, H&E staining of a 4-mm skin biopsy punch of one of the patients with IV
from whom keratinocytes were isolated for this study. General morphology and stratification of the
epidermis is normal, except for absence of the FLG-containing keratohyalin granules that are normally
present in the stratum granulosum. B, FLG protein staining is negative, revealing complete loss of the
FLG expression in this patient. Scale bar5 100 mm. C, Keratinocytes from patients with IV used in this study
carry the 2 most frequently occurring mutations R501X and 2282del4 located on the first repeat of the FLG
gene. D, FLG mRNA expression analysis of FLG2/2 and FLG1/1 epidermal equivalents. EDC, Epidermal
differentiation complex; H&E, hematoxylin and eosin. Bars represent mean (N 5 2 for both groups).
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FIG E3. Epidermal thickness of FLG1/1 and FLG2/2 HEEs. Thickness of the
viable epidermal layers (stratum basale, stratum spinosum, stratum granu-
losum) and the entire epidermal thickness were measured in unstimulated
(control) and TH2-cytokine-stimulated HEEs. Measurements were taken
using AxioVison software. Two-way ANOVA was performed to determine
significant changes in epidermal thickness.
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FIG E4. mRNA expression changes on TH2 stimulation of HEEs. HEEs of 11
primary keratinocyte donors (n 5 6 FLG1/1, n 5 5 FLG2/2) were stimulated
with TH2 cytokines IL-4 and IL-13 during air-liquid interface culture.
Epidermal differentiation and TJ genes were significantly downregulated
on TH2 stimulation. Two-way ANOVA statistical analysis was performed
to test the influence of the TH2 stimulation. Data are represented as
mean 6 SEM. *P < .05, **P < .001, and ***P < .0001.
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FIG E5. mRNA expression data of FLG1/1 and FLG2/2 HEEs. Relative mRNA expression levels of genes
concerning epidermal differentiation (A) and TJs (B). The figures present quantitative PCR expression
data of HEEs of 11 primary keratinocyte donors (n 5 6 FLG1/1, n 5 5 FLG2/2) unstimulated (control) or
with TH2 stimulation. The house keeping gene ribosomal phosphoprotein P0 (RPLP0) was used for
normalization. Two-way ANOVA was performed to determine significant changes in expression levels
between FLG1/1 and FLG2/2 HEEs.
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FIG E5. (Continued).
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FIG E6. SDS application disrupts the epidermal barrier in vitro. A, Representative H&E staining of an HEE
after 90 minutes topical application of 0.5% SDS to disrupt the epidermal barrier. B, Immunofluorescence
detection of LY (green), which was incubated for 60 minutes after SDS application, in combination
with DAPI staining for cell nuclei (blue). DAPI, 49-6-Diamidino-2-phenylindole, dihydrochloride. H&E,
Hematoxylin and eosin. Scale bar 5 100 mm. N 5 3.
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FIG E7. Normal barrier function of FLG2/2 HEEs. A, H&E staining of FLG1/1 and FLG2/2 HEEs used for
barrier permeability assays after 8 days of air-liquid interface culture. B, Staining of biotin, which was
incubated apically on the HEEs for 60 minutes, shows equal epidermal barrier function in both genotypes
as the dye remained on top of the SC, not reaching the viable cell layers of the epidermis. C, Lucifer yellow
dye (green) was incubated apically on the HEEs for 60 minutes. The fluorescent dye remains on top of the
stratum corneum only, revealing equal barrier function in both genotypes. Nuclei were stained with DAPI
(blue). H&E, Hematoxylin and eosin. DAPI, 49-6-Diamidino-2-phenylindole, dihydrochloride. Scale
bar 5 100 mm.
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TABLE E1. Filaggrin knockdown studies using in vitro 3D skin models
Authors Keratinocyte source Knockdown Skin equivalent features Barrier assay Barrier permeability
Mildner et al 2010E1 Neonatal foreskin KCs siRNA + lipofectamine
85% mRNA
95% protein
Less keratohyalin granules
Normal SC
Impaired lamellar bodies
60% decrease in UCA
Increased UV sensitivity
Increased DNA damage
LY penetration Increased permeability
Gruber et al. 2011E2 (adapted
from Mildner et alE1)
Neonatal foreskin KCs siRNA + lipofectamine
>90% (not shown)
Normal keratin intermediate
filament integrity
Lanthanum perfusion Increased paracellular
permeability
Kuchler et al 2011E3 (adapted
from Mildner et alE1)
Neonatal foreskin KCs siRNA + HiPerFect
82% mRNA
Intercellular and intracellular
spongiosis
1% SDS for 15 min followed
by testosterone and
caffeine absorption
Increased IL-6 and IL-8
release and testosterone
absorption
van Drongelen et al 2013E4 N/TERT immortalized KC
cell line
shRNA + electroporation
85% mRNA
80% protein
Normal epidermal
morphogenesis
Normal SC lipid organization
and lipid composition
Butyl-PABA No differences in
permeability
Vavrova et al 2014E5 (adapted
from Mildner et alE1)
Neonatal foreskin KCs siRNA + lipofectamine
75% mRNA
Less NMF
Normal skin surface pH
Altered lipid profile
Testosterone and caffeine
absorption
No differences in absorption
(not shown)
Pendaries et al 2014E6 Adult epidermal KCs shRNA + lentivirus
90% mRNA
90% protein
Less KC layers
Reduced SC thickness
Less keratohyalin granules
Impaired SC formation
Reduction in proliferation
Normal skin surface pH
Decreased NMF levels
Increased UV sensitivity
Altered epidermal
differentiation
Activation pro-caspase 14
inhibition
LY penetration Increased permeability
Butyl-PABA, Butyl 4-aminobenzoate; KC, keratinocyte; NMF, natural moisturizing factor; N/TERT, normal human keratinocytes immortalized by stable human telomerase transfection; shRNA, small hairpin RNA (stable transduction);
siRNA, small interfering RNA (transient transfection); UCA, urocanic acid; UV, ultraviolet radiation.
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TABLE E2. Antibodies for immunohistochemistry and immuno-
fluorescence (boldface)
Target protein Antibody clone, manufacturer Dilution
Cytokeratin-10 DE-K10, Euro Diagnostics 1:100
Filaggrin NCL-Filaggrin, Novocastra 1:200
Loricrin PRB145P, Covance 1:2000
Transglutaminase-1 H-87, Santa Cruz 1:100
Involucrin MON-150, generated by our groupE13 1:20
Late cornified
envelope 3
Generated by our groupE14 1:5000
49,6-Diamidino-
2-phenylindole
Boehringer Mannheim 1:3000
Streptavidin Alexa
Fluor 594
Life Technologies 1:200
Claudin-1 JAY.8, Thermo Fisher Scientific 1:1500
Claudin-4 3E2C1, Thermo Fisher Scientific 1:700
Occludin N19, Santa Cruz 1:250
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TABLE E3. Primers used for quantitative PCR
HUGO symbol Alias gene name Forward primer 59-39 Reverse primer 39-59 E*
CASP14 Caspase 14 acaaaccatcccaacatacac gatatgtcctttcctcttcgt 2.12
CLDN1 Claudin 1 ccagtcaatgccaggtacga ttggatagggccttggtgtt 1.78
CLDN4 Claudin 4 gctgtaaacaggtttgggca tcagaggggatcagtctcca 1.85
FLG Filaggrin acttcactgagtttcttctgatggtatt tccagacttgagggtctttttctg 1.89
FLG2 Filaggrin 2 accaggttcacttaaacttgca atgacatccactgtgtctggatc 1.96
HRNR Hornerin tacaaggcgtcatcactgtcatc atctggatcgtttggattcttcag 2.12
IVL Involucrin acttatttcgggtccgctaggt gagacatgtagagggacagagtcaag 1.93
LCE2A Late cornified envelope 2A ggacctgtcccagagtgatg gatccaggatgggctcttg 2.10
LOR Loricrin aggttaagacatgaaggatttgcaa ggcaccgatgggcttagag 2.08
OCLN Occludin attggtcaccgagggagga taaaccaatctgctgcgtccta 1.86
RPLP0 hARP, 60S acidic ribosomal protein P0 caccattgaaatcctgagtgatgt tgaccagcccaaaggagaag 2.02
TGM1 Transglutaminase 1 cccccgcaatgagatctaca atcctcatggtccacgtacaca 1.99
*E is efficiency as fold increase in fluorescence per PCR cycle.
J ALLERGY CLIN IMMUNOL
nnn 2016
3.e13 LETTER TO THE EDITOR
